Dermatological toxicities induced by T-cell-redirecting G protein-coupled receptor family C class 5 member D bispecific antibody talquetamab

J Am Acad Dermatol. 2024 Feb;90(2):376-377. doi: 10.1016/j.jaad.2023.08.094. Epub 2023 Sep 22.

Authors

Marion Lery¹, Aurore Perrot², Ariadna Ortiz-Brugués¹, Emmanuelle Vigarios³, Diana Anghel¹, Pierre Bories², Vincent Sibaud⁴

Affiliations

¹ Department of Onco-Dermatology, Cancer University Institute, Toulouse Oncopole, Toulouse, France.
² Department of Haematology, Cancer University Institute, Toulouse Oncopole, Toulouse, France.
³ Department of Oral Medicine, Cancer University Institute, Toulouse Oncopole, Toulouse, France.
⁴ Department of Onco-Dermatology, Cancer University Institute, Toulouse Oncopole, Toulouse, France. Electronic address: sibaud.vincent@iuct-oncopole.fr.

PMID: 37742842
DOI: 10.1016/j.jaad.2023.08.094

No abstract available

Keywords: GPRC5D; dysgeusia; hand foot syndrome; multiple myeloma; onycholysis; onychomadesis; talquetamab; xerostomia.

MeSH terms

Antibodies, Bispecific* / adverse effects
Humans
Multiple Myeloma*
Protein C
Receptors, G-Protein-Coupled
T-Lymphocytes

Substances

Protein C
Antibodies, Bispecific
Receptors, G-Protein-Coupled